Hôpital Claude Huriez, CHRU
Lille, France
NCT Number: NCT03271320
The primary objective is to assess the burden of aesthetic complication in systemic sclerosis. Systemic sclerosis is associated with changes in skin aspect which can impact the appearance. Aesthetic burden will be assessed through several scales and compared to a control group of health subjects.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Lille, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
appearance scales : AVS; ASWAP; DAS 59
Time frame: Baseline
Visual scale for aesthetic burden from 0 to 10
Time frame: Baseline
The SWAP measures body image dissatisfaction in persons with visible disfigurement
Time frame: Baseline
The Derriford Appearance Scales measure the spectrum of psychological distress and dysfunction that is characteristic of disfigurements, deformities and aesthetic problems of appearance.
Time frame: Baseline
The Multidimensional Body-Self Relations Questionnaire (MBSRQ) is a 69-item self-report inventory for the assessment of self-attitudinal aspects of the body-image construct.
University Hospital, Lille
Other
Acronym: SCLERO-ESTHET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04301596
Connective Tissue Diseases, Scleroderma, Systemic
Montpellier, France
View Trial DetailsNCT07012655
Connective Tissue Diseases, Scleroderma, Systemic
Asyut, Egypt
View Trial DetailsNCT01395732
Connective Tissue Diseases, Digital Ulcers
Amsterdam, Netherlands
View Trial DetailsNCT04995588
Connective Tissue Diseases, Scleroderma, Systemic
Poitiers, France
View Trial Details